首页> 外文期刊>Osteoarthritis and cartilage >Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee.
【24h】

Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee.

机译:来自一项随机临床研究的关节软骨活组织检查的形态学分析,比较了500-730 kDa的透明质酸钠(Hyalgan)和醋酸甲泼尼龙对膝关节原发性骨关节炎的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Histomorphometric study on cartilage samples taken from osteoarthritic human knees before and 6 months after intraarticular injections of a specific fraction (500-730 kDa) of hyaluronan. The results obtained with hyaluronan were compared with the results of methylprednisolone acetate treatment. METHODS: Twenty-four subjects with primary osteoarthritis (OA) of the knee were considered. Eleven patients were treated with Hyaluronan (Hyalgan), 20 mg/2 ml once a week for 5 weeks) and 13 with methylprednisolone (Depo-Medrol, 40 mg/1 ml once a week for 3 weeks). At the time of baseline and after 6 months from the start of treatment, biopsies of cartilage were taken and processed for electron microscopy. Articular surface morphology, territorial matrix, chondrocyte number and ultrastructure were characterized by a set of morphometric parameters. Samples from 19 informed patients showing no arthroscopic sign of OA were also used for comparison. RESULTS: Six months after hyaluronan treatment a significant reconstitution of the superficial layer were observed together with an improvement in chondrocyte density and territorial matrix appearance. Furthermore, chondrocytes appeared significantly improved in their metabolism, as indicated by the increased extension of the synthetic structures and mitochondria with respect to the organelles having catabolic or storage functions. Hyaluronan treatment produced results that were significantly superior to those delivered with Methylprednisolone in almost all the morphometric estimators.CONCLUSIONS: These results cannot be explained simply by temporary restoration of the synovial fluid viscoelasticity, and provide further evidence that the specific fraction of hyaluronan used in this study is a useful tool in OA treatment, with a potential structure-modifying activity. Copyright 2001 OsteoArthritis Research Society International.
机译:目的:关节腔内注射特定比例的透明质酸(500-730 kDa)之前和之后6个月,从骨关节炎人膝盖获取的软骨样品的组织形态计量学研究。将乙酰透明质酸获得的结果与乙酸甲基泼尼松龙的处理结果进行比较。方法:二十四例膝关节原发性骨关节炎(OA)患者被纳入研究。 11例患者接受透明质酸(Hyalgan)治疗,每周一次,每次20 mg / 2 ml,持续5周; 13例患者接受甲泼尼龙(Depo-Medrol,40 mg / 1 ml,一周一次,持续3周)。在基线时和治疗开始后的6个月后,进行软骨活检并进行电子显微镜检查。用一组形态学参数表征关节表面形态,领土基质,软骨细胞数量和超微结构。还使用了来自19位知情患者的样本,这些患者没有显示关节镜检查的OA征象。结果:透明质酸治疗六个月后,观察到表层明显重建,软骨细胞密度和领土基质外观得到改善。此外,相对于具有分解代谢或储存功能的细胞器,合成结构和线粒体的延伸增加表明,软骨细胞的代谢明显改善。透明质酸治疗所产生的结果在几乎所有形态学估计量中均显着优于甲基强的松龙。结论:这些结果不能简单地通过暂时恢复滑液粘弹性来解释,并提供进一步的证据表明透明质酸在这种情况下使用的特定比例研究是OA治疗的有用工具,具有潜在的结构修饰活性。版权所有2001国际骨关节炎研究协会。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号